Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Assets: 2013-2024

Historic Assets for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Dec 2024 value amounting to $1.6 billion.

  • Amphastar Pharmaceuticals' Assets rose 7.83% to $1.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 7.83%. This contributed to the annual value of $1.6 billion for FY2024, which is 4.27% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Assets stood at $1.6 billion for FY2024, which was up 4.27% from $1.5 billion recorded in FY2023.
  • Amphastar Pharmaceuticals' Assets' 5-year high stood at $1.6 billion during FY2024, with a 5-year trough of $631.2 million in FY2020.
  • Over the past 3 years, Amphastar Pharmaceuticals' median Assets value was $1.5 billion (recorded in 2023), while the average stood at $1.3 billion.
  • Data for Amphastar Pharmaceuticals' Assets shows a peak YoY surged of 103.90% (in 2023) over the last 5 years.
  • Amphastar Pharmaceuticals' Assets (Yearly) stood at $631.2 million in 2020, then rose by 6.38% to $671.5 million in 2021, then grew by 10.49% to $742.0 million in 2022, then skyrocketed by 103.90% to $1.5 billion in 2023, then climbed by 4.27% to $1.6 billion in 2024.